Skip to main content
. Author manuscript; available in PMC: 2013 May 15.
Published in final edited form as: Clin Cancer Res. 2012 Mar 31;18(10):2905–2912. doi: 10.1158/1078-0432.CCR-11-2994

Fig. 1.

Fig. 1

Survival curves for the metformin group (solid line) and nonmetformin group (dotted line) in patients with resectable (panel A), unresectable (panel B), and metastatic (panel C) pancreatic cancer. P values (log rank test) were 0.293, 0.001, and 0.482 for panels A, B, and C, respectively.